The anti-inflamm-aging and hepatoprotective effects of huperzine A in d-galactose-treated rats

Mechanisms of Ageing and Development

Volumn 134, Issue 3-4, 2013, Pages 89-97

  Ruan, Qingwei ^a   Liu, Fang ^a   Gao, Zhanjuan ^a   Kong, Deqiu ^b   Hu, Xiaona ^a   Shi, Dongmei ^a   Bao, Zhijun ^a   Yu, Zhuowei ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cholinergic anti inflammatory pathway; D Galactose; Huperzine A; Inflamm aging; Inflammation and anti inflammation; Nuclear factor kappa B

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETA GALACTOSIDASE; CHOLINE ACETYLTRANSFERASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GALACTOSE; HUPERZINE A; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AGING; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; INFLAMMAGING; LIVER FUNCTION TEST; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

AGING; ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL AGING; CYTOKINES; GALACTOSE; INFLAMMATION; LIVER; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SESQUITERPENES;

RATTUS;

EID: 84875053027     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2012.12.005     Document Type: Article

References (50)

1. Baynes J.W. The role of AGEs in aging: causation or correlation. Experimental Gerontology 2001, 36(9):1527-1537.
2. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Susarla S., Czura C.J., Tracey K.J. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. Journal of Vascular Surgery 2002, 36(6):1231-1236.
3. Best T.M., Fiebig R., Corr D.T., Brickson S., Ji L. Free radical activity, antioxidant enzyme, and glutathione changes with muscle stretch injury in rabbits. Journal of Applied Physiology 1999, 87(1):74-82.
4. Brenner T., Nizri E., Irony-Tur-Sinai M., Hamra-Amitay Y., Wirguin I. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation. Journal of Neuroimmunology 2008, 201/202:121-127.
5. Brunk U.T., Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. European Journal of Biochemistry 2002, 269(8):1996-2002.
6. Cannizzo E.S., Clement C.C., Sahu R., Follo C., Santambrogio L. Oxidative stress, inflamm-aging and immunosenescence. Journal of Proteomics 2011, 74(11):2313-2323.
7. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nature Reviews Immunology 2010, 10(12):826-837.
8. Chen H.L., Wang C.H., Kuo Y.W., Tsai C.H. Antioxidative and hepatoprotective effects of fructo-oligosaccharide in d-galactose-treated Balb/cJ mice. British Journal of Nutrition 2011, 105(6):805-809.
9. Chen Q.M. Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints. Annals of the New York Academy of Sciences 2000, 908:111-125.
10. Csiszar A., Wang M., Lakatta E.G., Ungvari Z.I. Inflammation and endothelial dysfunction during aging: role of NF-κB. Journal of Applied Physiology 2008, 105:1333-1341.
11. Czura C.J., Tracey K.J. Autonomic neural regulation of immunity. Journal of Internal Medicine 2005, 257(2):156-166.
12. De la Fuente M., Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Current Pharmaceutical Design 2009, 15(26):3003-3026.
13. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 2000, 908:244-254.
14. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mechanism of Aging & Development 2007, 128:92-105.
15. Gallowitsch-Puerta M., Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sciences 2007, 80(24/25):2325-2329.
16. Giacinti C., Giordano A. RB and cell cycle progression. Oncogene 2006, 25(38):5220-5227.
17. Gill R., Tsung A., Billiar T. Linking oxidative stress to inflammation: toll-like receptors. Free Radical Biology and Medicine 2010, 48(9):1121-1132.
18. Grando S.A., Kawashima K., Wessler I. Introduction: the non-neuronal cholinergic system in humans. Life Sciences 2003, 72(18-19):2009-2012.
19. Gordon R.K., Nigam S.V., Weitz J.A., Dave J.R., Doctor B.P., Ved H.S. The NMDA receptor iron channel: a site for binding of huperzine A. Journal of applied toxicology 2001, 21:S47-S51.
20. Guarini S., Altavilla D., Cainazzo M.M., Giuliani D., Bigiani A., Marini H., Squadrito G., Minutoli L., Bertolini A., Marini R., Adamo E.B., Venuti F.S., Squadrito F. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003, 107(8):1189-1194.
21. Helenius M., Hanninen M., Lehtinen S.K., Salminen A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochemical Journal 1996, 318(Pt 2):603-608.
22. Itahana K., Dimri G., Campisi J. Regulation of cellular senescence by p53. European Journal of Biochemistry 2001, 268(10):2784-2791.
23. Itahana K., Zou Y., Itahana Y., Martinez J.L., Beausejour C., Jacobs J.J., Van Lohuizen M., Band V., Campisi J., Dimri G.P. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Molecular and Cellular Biology 2003, 23(1):389-401.
24. Kumar A., Prakash A., Dogra S. Centella asiatica attenuates d-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice. International Journal of Alzheimer's Disease 2011, 2011:347569.
25. Kumar A., Prakash A., Dogra S. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by d-galactose in mice. Food and Chemical Toxicology 2010, 48(2):626-632.
26. Liu Y., Sanoff H.K., Cho H., Burd C.E., Torrice C., Ibrahim J.G., Thomas N.E., Sharpless N.E. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell 2009, 8(4):439-448.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
28. Ma X.C., Xin J., Wang H.X., Zhang T., Tu Z.H. Acute effects of huperzine A and tacrine on rat liver. Acta Pharmacologica Sinica 2003, 24:247-250.
29. Martinon F. Signaling by ROS drives inflammasome activation. European Journal of Immunology 2010, 40(3):616-619.
30. Nizri E., Hamra-Amitay Y., Sicsic C., Lavon I., Brenner T. Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology 2006, 50(5):540-547.
31. Ohtani N., Yamakoshi K., Takahashi A., Hara E. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. The Journal of Medical Investigation 2004, 51(3/4):146-153.
32. Pavlov V.A., Parrish W.R., Rosas-Ballina M., Ochani M., Puerta M., Ochani K., Chavan S., A.I-Abed Y., Tracey K.J. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain, Behavior, and Immunity 2009, 23:41-45.
33. Pollak Y., Gilboa A., Ben-Menachem O., Ben-Hur T., Soreq H., Yirmiya R. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Annals of Neurology 2005, 57(5):741-745.
34. Radak Z., Chung H.Y., Naito H., Takahashi R., Jung K.J., Kim H.J., Goto S. Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise. FASEB Journal 2004, 18(6):749-750.
35. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., Tracey K.J., Al-Abed Y., Metz C.N. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. Journal of Experimental Medicine 2005, 201(7):1113-1123.
36. Satyanarayana A., Wiemann S.U., Buer J., Lauber J., Dittmar K.E., Wustefeld T., Blasco M.A., Manns M.P., Rudolph K.L. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. The EMBO Journal 2003, 22(15):4003-4013.
37. Shang L., Ananthakrishnan R., Li Q., Quadri N., Abdillahi M., Zhu Z., Qu W., Rosario R., Toure F., Yan S.F., Schmidt A.M., Ramasamy R. RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. PLoS ONE 2010, 5(4):e10092.
38. Shapiro G.I., Edwards C.D., Ewen M.E., Rollins B.J. p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Molecular and Cellular Biology 1998, 18(1):378-387.
39. Singh S.P., Kalra R., Puttfarcken P., Puttfarcken P., Kozak A., Tesfaigzi J., Sopori M.L. Acute and chronic nicotine exposures modulate the immune system through different pathways. Toxicology and Applied Pharmacology 2000, 164:65.
40. Song X., Bao M., Li D., Li Y.M. Advanced glycation in d-galactose induced mouse aging model. Mechanisms of Ageing and Development 1999, 108(3):239-251.
41. Stein G.H., Drullinger L.F., Soulard A., Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Molecular and Cellular Biology 1999, 19(3):2109-2117.
42. Tabet N. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!. Age and Ageing 2006, 35(4):336-338.
43. Tian Y., Zou B., Yang L., Xu S.F., Yang J., Yao P., Li C.M. High molecular weight persimmon tanin ameliorates cognition deficits and attenuates oxidative damage in senescent mice induced by d-galactose. Food and Chemical Toxicology 2011, 49(8):1728-1736.
44. Ungvari Z., Parrado-Fernandez C., Csiszar A., de Cabo R. Mechanisms underling caloric restriction and lifespan regulation: implications for vascular aging. Circulation Research 2008, 102:519-528.
45. Wang R., Yan H., Tang X. Progress in studies of huperzine A, a natural cholinesterase inhibitor from chinese herbal medicine. Acta Pharmacologica Sinica 2006, 27(1):1-26.
46. Wang Z.F., Wang J., Zhang H.Y., Tang X.C. Huperzine A exhibits anti-inflammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia. Journal of Neurochemistry 2008, 106(4):1594-1603.
47. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 1996, 313(Pt 1):17-29.
48. Zhang H.Y., Yan H., Tang X.C. Non-cholinergic effects of huperzine A: beyond inhibition of Acetylcholinesterase. Cellular and Molecular Neurobiology 2008, 28:173-183.
49. Zhang Z.F., Fan S.H., Zheng Y.L., Lu J., Wu D.M., Shan Q., Hu B. Purple sweet potato color attenuates oxidative stress and inflammatory response induced by d-galactose in mouse liver. Food and Chemical Toxicology 2009, 47(2):496-501.
50. Zhong S.Z., Ge Q.H., Qu R., Li Q., Ma S.P. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice. Journal of the Neurological Sciences 2009, 277(1-2):58-64.